Evidence map›Paper›PMID 36357903›Full record

Observational studyBMC urology2022

High stone-free rate immediately after suctioning flexible ureteroscopy with Intelligent pressure-control in treating upper urinary tract calculi.

Xingjian Gao, Zedong Zhang, Xinwei Li, Weiping Cai, Bin Zheng, Yijin Lu, Hualong Zhao, Junhong You, Gangfeng Zheng, Weilong Bao and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Xingjian Gao *Department of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Zedong Zhang *Department of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Xinwei LiDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Weiping CaiDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Bin ZhengDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Yijin LuDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Hualong ZhaoDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Junhong YouDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Gangfeng ZhengDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Weilong BaoDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Yutong LaiDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China.
Yisong LvDepartment of Urology, The General Hospital of Fujian Energy Group, No.18 Houxian Road, Fuzhou, 350003, Fujian Province, People's Republic of China. 32912630@qq.com.
Fujian Petrochemical Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe retrospective observational study aimed to evaluate the safety and efficacy of suctioning flexible ureteroscopy with Intelligent pressure-control (SFUI) on treating upper urinary tract calculi in a large cohort.

methodsBetween July 2020 and August 2021, 278 patients with upper urinary tract calculi who underwent SFUI in our hospital were enrolled. Outcomes were stone-free rate (SFR) in one session and one-month after SFUI treatment, and complications scored by the Clavien-Dindo classification.

resultsA total of 310 kidneys underwent SFUI were included. The median surgery time was 75 min (ranged 60-110 min). One session and one-month SFRs were 80.65% and 82.26%, respectively. The one-session SFR was ≧ 87% in patients with Guy's stone score of Grade I among stone size < 40 mm. Risk factors for unsuccessful stone-free in one session were stone history (adjusted odds ratio (aOR): 2.39, 95% confidence interval (CI): 1.21-4.73), stone size of 40-49 mm (aOR: 4.37, 95% CI: 1.16-16.45), Guy's stone score ≧ Grade II (Grade II, aOR: 3.54, 95% CI: 1.18-10.59; Grade III, aOR: 10.95, 95% CI: 2.65-45.25). The incidence of Clavien-Dindo grade II-III complication was 3.26%. Complication is associated with Guy's stone score III (aOR: 22.36, 95% CI: 1.81-276.36).

conclusionSFUI shows good safety and efficiency on treating upper urinary tract calculi. Patients with stone size < 40 mm or Guy's stone score of Grade I have a high chance to reach stone-free after SFUI treatment.

Indexed as

Kidney CalculiUrinary CalculiUrinary TractHumansRetrospective StudiesTreatment OutcomeUreteroscopesUreteroscopyClavien-Dindo classificationGuy’s stone scoreStone-free rateSuctioning flexible ureteroscopy with Intelligent pressure-controlUpper urinary tract stone

Identifiers

PMID36357903
PMCPMC9650831
OpenAlexW4308883350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.